Recent Updates
Recently added Catalysts
PROF Positive Sentiment

Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

Monday, February 19, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Profound Medical Corp. will present at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022. The presentation will focus on the company's advancements in customizable, incision-free therapies for tissue ablation. This engagement highlights the company's commitment to investor relations and market presence.
Price reaction · baseline $8.5 (2024-02-16 close) · 10 other PROF headline(s) in the window, move may be shared
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Profound Medical is actively engaging with investors.
  • The company is showcasing its innovative medical device solutions.
  • Management is providing updates on business progress.

Full Press Release Details

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2022 at 2:00 p.m. Eastern Time at the Metro Toronto Convention Centre.

Frequently Asked Questions

When is Profound Medical presenting at the conference?

Profound Medical will present on May 2, 2022, at 2:00 p.m. Eastern Time.

Where is the Bloom Burton Healthcare Investor Conference held?

The conference will take place at the Metro Toronto Convention Centre.

What does Profound Medical specialize in?

Profound Medical develops customizable, incision-free therapies for tissue ablation.

Who will present at the Bloom Burton conference?

Management from Profound Medical will provide updates during the presentation.

ShareAdd on Google
Tags: PROF Viatris Investor Conferences Healthcare Profound Medical Bloom Burton healthcare conference NASDAQ:PROF medical device
Last updated: Feb 19, 2024

Biotech snapshot

Cash runway
$38M liquidity · $4M/mo burn
~10 mo
Medium dilution risk